{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:04:38Z","timestamp":1790197478351,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ebr.2026.100898","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:50:08Z","timestamp":1788850208000},"page":"100898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of diazepam nasal spray in Japanese Pediatric patients with or at risk for status epilepticus: a phase 3, Multicenter, open-label clinical trial"],"prefix":"10.1016","volume":"36","author":[{"given":"Eiji","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Itomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikuo","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2026.100898_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100898_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.10286","article-title":"Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland","volume":"52","author":"Sillanp\u00e4\u00e4","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebr.2026.100898_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2022.02.012","article-title":"Recurrent status epilepticus: clinical features and recurrence risk in an adult population","volume":"97","author":"Orlandi","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2026.100898_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.794086","article-title":"The occurrence of seizure clusters in patients with epilepsy is partly determined by epilepsy severity: a single-center retrospective observational study","volume":"12","author":"Zhong","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebr.2026.100898_bb0025","article-title":"The unmet need for rapid epileptic seizure termination (REST)","volume":"15","author":"Asnis-Alibozek","year":"2020","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.ebr.2026.100898_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ebr.2026.100898_bb0035","series-title":"National Institute for health and care excellence. Epilepsies in children, young people and adults (NG217) [internet]","year":"2025"},{"key":"10.1016\/j.ebr.2026.100898_bb0045","year":"2025","journal-title":"Japanese [Internet]"},{"key":"10.1016\/j.ebr.2026.100898_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-020-00720-w","article-title":"Efficacy, tolerability, and safety of concentrated intranasal midazolam spray as emergency medication in epilepsy patients during video-EEG monitoring","volume":"34","author":"von Blomberg","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ebr.2026.100898_bb0055","first-page":"134","article-title":"Mobile application-based questionnaire survey on the actual use of oral midazolam solution","volume":"55","author":"Kuki","year":"2023","journal-title":"No Hattatsu"},{"key":"10.1016\/j.ebr.2026.100898_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/epi.16449","article-title":"Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100898_bb0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/cpdd.767","article-title":"Evaluation of pharmacokinetics and dose proportionality of diazepam after intranasal administration of NRL-1 to healthy volunteers","volume":"9","author":"Tanimoto","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ebr.2026.100898_bb0075","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1111\/epi.18473","article-title":"Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5years","volume":"66","author":"Segal","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100898_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3999\/jscpt.55.4_175","article-title":"A phase 1, randomized, open-label, three-period crossover study to evaluate pharmacokinetics, dose proportionality, and safety after single intranasal administration of diazepam nasal spray (NRL-1) in healthy Japanese participants","volume":"55","author":"Onuma","year":"2024","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"10.1016\/j.ebr.2026.100898_bb0085","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/epi.17041","article-title":"Final results from a phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100898_bb0090","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1542\/peds.2007-0930","article-title":"Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial","volume":"121","author":"Mpimbaza","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ebr.2026.100898_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ebr.2026.100898_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ebr.2026.100898_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106651","article-title":"A phase 3 open-label study of the efficacy, safety and pharmacokinetics of buccally administered midazolam hydrochloride for the treatment of status epilepticus in pediatric Japanese subjects","volume":"174","author":"Yoshinaga","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2026.100898_bb0110","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/archneur.59.12.1915","article-title":"Rectal diazepam gel for treatment of acute repetitive seizures in adults","volume":"59","author":"Cereghino","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ebr.2026.100898_bb0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/epi.17177","article-title":"Use of second doses of Valtoco\u00ae (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: results from a phase 3, open-label, repeat-dose safety study","volume":"63","author":"Sperling","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100898_bb0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/epd2.20243","article-title":"Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: consensus recommendations of an expert working group","volume":"26","author":"Pina-Garza","year":"2024","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebr.2026.100898_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109914","article-title":"Emergency management of pediatric epileptic seizures in non-hospital settings in Japan","volume":"158","author":"Okazaki","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"Pt A","key":"10.1016\/j.ebr.2026.100898_bb0130","article-title":"Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study","volume":"121","author":"Penovich","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100898_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(24)00430-7","article-title":"Diagnosis and management of status epilepticus: improving the status quo","volume":"24","author":"Gettings","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebr.2026.100898_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3805\/jjes.43.75","article-title":"A proposed rapid therapeutic intervention for seizures with high risk of progressing to status epilepticus","volume":"43","author":"Nakagawa","year":"2025","journal-title":"J Jpn Epilepsy Soc"},{"key":"10.1016\/j.ebr.2026.100898_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40120-023-00568-4","article-title":"Rapid rescue treatment with diazepam nasal spray leads to faster seizure cluster termination in epilepsy: an exploratory post hoc cohort analysis","volume":"13","author":"Misra","year":"2024","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ebr.2026.100898_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2022.04.011","article-title":"Safety of diazepam nasal spray in children and adolescents with epilepsy: results from a long-term phase 3 safety study","volume":"132","author":"Tarquinio","year":"2022","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ebr.2026.100898_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/PPA.S447028","article-title":"Taking a newer, faster, intranasal route: a narrative review of transitioning to a less-invasive rescue treatment for seizure clusters","volume":"18","author":"Peters","year":"2024","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ebr.2026.100898_bb0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/pharmaceutics12121167","article-title":"A short review on the intranasal delivery of diazepam for treating acute repetitive seizures","volume":"12","author":"Boddu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ebr.2026.100898_bb0165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","article-title":"A comparison of rectal diazepam gel and placebo for acute repetitive seizures","volume":"338","author":"Dreifuss","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebr.2026.100898_bb0170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.51.5.1274","article-title":"Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The north American Diastat study group","volume":"51","author":"Cereghino","year":"1998","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986426000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986426000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:25:35Z","timestamp":1790195135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986426000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S2589986426000523"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2026.100898","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of diazepam nasal spray in Japanese Pediatric patients with or at risk for status epilepticus: a phase 3, Multicenter, open-label clinical trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2026.100898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100898"}}